Skip to main content
    C

    CorMedix Inc (CRMD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.67
    -0.15 (-3.11%)

    Market Cap: $370.64M

    Last updated: Nov 17, 2026 at 4:18 PM ET

    CorMedix Inc (CRMD) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    CorMedix (CRMD) has a latest price of $4.67 on Nov 17, 2026, 64.1% below its 52-week high of $13.02. Its price fell 58.5% over the past 12 months. The month-end price fell 45.5% over the 10 years through Oct 2026, a compound annual decline of 5.9%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $15.00 in Feb 2021 and its lowest $0.90 in Mar 2018, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CRMD with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRMD.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 45.2%, and over 6 months it fell 40.3%. The month-end price rose 63.6% over the 3 years through Oct 2026, a compound annual rate of 17.8%.

    PeriodChange
    1 month-36.7%
    3 months-45.2%
    6 months-40.3%
    12 months-58.5%
    12 months, with dividends-58.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+63.6%+17.8%
    5 years+17.2%+3.2%
    10 years-45.5%-5.9%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2018, when the price rose 158.0%, and its weakest was 2017, when it fell 67.3%.

    YearCloseChange
    2026 through Oct 2026$5.70-51.0%
    2025$11.63+43.6%
    2024$8.10+115.4%
    2023$3.76-10.9%
    2022$4.22-7.3%
    2021$4.55-38.8%
    2020$7.43+2.1%
    2019$7.28+12.9%
    2018$6.45+158.0%
    2017$2.50-67.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 33.6% below its 50-day average of $7.04 and 38.0% below its 200-day average of $7.53.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$4.67
    52-week high$13.02-64.1%
    52-week low$4.65+0.4%
    50-day average$7.04-33.6%
    200-day average$7.53-38.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 71.9%.

    MeasureValue
    1-year beta1.34
    Largest fall, 1 year-63.4%
    Largest fall, 3 years-71.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CRMD

    What is CRMD's 1-year price change?

    CorMedix's price fell 58.5% over the past 12 months. With dividends included, the 12-month total return was -58.5%.

    What is CRMD's 5-year price change?

    CorMedix's month-end price rose 17.2% over the 5 years through Oct 2026, a compound annual rate of 3.2%. These figures leave out dividends.

    What is CRMD's 52-week high and low?

    CorMedix's 52-week high is $13.02 and its 52-week low is $4.65. Its latest price of $4.67 on Nov 17, 2026 is 64.1% below the high.

    What is CRMD's beta?

    CorMedix's 1-year beta against the S&P 500 is 1.34, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 63.4%.

    Is the CRMD chart free?

    Yes. Advanced Charting for CRMD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.